Page contentsCurrent versionDocument historyRelated contentTopicsThis document provides product-specific guidance on colchicine.Keywords: Bioequivalence, generics, colchicineAbbreviations:BCS Classification: Biopharmaceutics Classification SystemAUC0-t: area under the plasma concentration curve from administration to last observed concentration at time tAUC0-72: area under the plasma concentration curve from administration to last observed concentration at 72 hoursCmax: maximum plasma concentration Current version Colchicine tablet 0.5 mg and 1 mg product-specific bioequivalence guidanceAdoptedReference Number: EMA/CHMP/35552/2019Legal effective date: 01/04/2020 English (EN) (125.82 KB - PDF)First published: 15/10/2019View Document history Draft Colchicine tablet 0.5 mg and 1 mg product-specific bioequivalence guidanceDraft: consultation closedConsultation dates: 08/03/2019 to 30/06/2019Reference Number: EMA/CHMP/35552/2019 English (EN) (124.21 KB - PDF)First published: 08/03/2019View Related content Product-specific bioequivalence guidanceTopicsScientific guidelinesShare this page